Ensayo clínico NCT05949606 · Non-small Cell Lung Cancer
Ensayo clínico NCT05949606 (fase I/II) figura como «activo (sin reclutamiento)» en ClinicalTrials.gov.
Patología: Non-small Cell Lung Cancer · Intervenciones registradas: SI-B001, SI-B003 · Fechas registradas (fuente): 2023-10-30, 2026-12, 2023-07-18, 2026-08-28.
Resumen del estudio (fuente: ClinicalTrials.gov, texto original en inglés):
Phase Ib: To observe the safety and tolerability of the combination of SI-B001 and SI-B003, and to determine the recommended dose of phase II clinical study (RP2D) in the indication of locally advanced or metastatic non-small cell lung cancer. Phase II: To evaluate the efficacy of SI-B001+SI-B003 combination with or without chemotherapy in patients with locally advanced or metastatic non-small cell lung cancer.